In an interview conducted at the 2024 American Society of Hematology Annual Meeting in San Diego, California, Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center,…
Systemic mastocytosis, a rare blood disorder, affects the entire body. There are many challenges associated with living with this systemic mastocytosis that are centered around reducing the frequency…
NEW YORK (Reuters Health) – Subcutaneous immunotherapy is at least as effective as drug therapy in controlling symptoms of seasonal allergic rhinitis, even in the first season after…
NEW YORK (Reuters Health) – After chemotherapy-induced remission of follicular lymphoma, vaccination with a patient-specific tumor-derived antigen improves disease-free survival, a multicenter team has shown. Furthermore, the vaccine…
NEW YORK (Reuters Health) – The longitudinal decline in lung function seen in patients with common variable immunodeficiency and X-linked agammaglobulinemia is related to immunoglobulin replacement level and…
NEW YORK (Reuters Health) – Methotrexate and azathioprine are similarly effective as systemic treatments for severe atopic dermatitis in adults, according to the results of a head-to-head trial…
NEW YORK (Reuters Health) – Based on the results of a double-blind comparative trial, an extract of a plant commonly known as butterbur is an effective treatment for…
NEW YORK (Reuters Health) – Results of an integrated analysis of pooled data from two clinical trials confirm that the recombinant peptide ecallantide (Kalbitor; Dyax Corp) reduces symptoms…
NEW YORK (Reuters Health) – Azathioprine has a moderate therapeutic effect in atopic dermatitis, and may also be useful for other dermatologic conditions, according to a report in…
NEW YORK (Reuters Health) – Adjunctive treatment with omalizumab can help patients with moderate to severe persistent allergic asthma achieve a lasting reduction in the amount of corticosteroids…
NEW YORK (Reuters Health) – When children develop a skin rash after being treated with a beta-lactam, the cause is more likely to be related to a viral…
NEW YORK (Reuters Health) – There’s a 25% chance that patients with hypersensitivity to cephalosporins will also react to penicillins, a European group reports, but the risk with…
